Vimarsana
Biggest News Aggregation in the World

Clearmind Panel News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Clearmind Panel. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Clearmind Panel Today - Breaking & Trending Today

Clearmind Medicine to Partner with Microdose for Psychedelic Capital: Mar 2022 Today, Thursday, March 24th - Vimarsana News

Clearmind Medicine to Partner with Microdose for Psychedelic Capital: Mar 2022 Today, Thursday, March 24th

Published: March 24, 2022

TORONTO, March 24, 2022 -- Clearmind Medicine Inc. , a psychedelic medicine biotech company focused on the discovery and development of novel psychedelic-derived therapeutics to solve widespread... | March 24, 2022

Source: marketscreener.com
Related Topics:
United StatesMark HadenAdi Zuloff ShaniVp Business DevelopmentClearmind Medicine IncFrankfurt Stock ExchangeMedicine IncNeither The Canadian Securities ExchangeClearmind PanelCanadian Securities ExchangeRegulation Services ProviderGlobenewswire IncStock ExchangePrivate PlacementUnited States Securities ActCynr Vent Stock ExchangePress ReleaseOlve Cyn Ca23258c1041
Microdose Psychedelic Insights: Clearmind Medicine to Partner with Microdose for Psychedelic Capital: Mar 2022 on Thursday, March 24th - Vimarsana News

Microdose Psychedelic Insights: Clearmind Medicine to Partner with Microdose for Psychedelic Capital: Mar 2022 on Thursday, March 24th

Published: March 23, 2022

Toronto, Ontario--(Newsfile Corp. - March 23, 2022) - Clearmind Medicine Inc. (CSE: CMND) (FSE: CWY0) (OTC Pink: CMNDF) ("Clearmind" or the "Company"), a psychedelic medicine biotech company focused on

Source: finanznachrichten.de
Related Topics:
United StatesMark HadenAdi Zuloff ShaniVp Business DevelopmentClearmind Medicine IncFrankfurt Stock ExchangeNewsfile CorpNeither The Canadian Securities ExchangeCanadian Securities ExchangeTime Of Clearmind PanelRegulation Services ProviderPsychedelic CapitalClearmind PanelPrivate PlacementUnited States Securities Act